Reporting and validation of gynaecological groupe euopeen de curietherapie european society for therapeutic radiology and oncology (ESTRO) brachytherapy recommendations for MR imageYBased dose volume parameters and clinical outcome with high doseYRate brachytherapy in cervical cancers a single-institution initial experience

International Journal of Gynecological Cancer

Volumn 21, Issue 6, 2011, Pages 1110-1116

  Mahantshetty, Umesh ^a   Swamidas, Jamema ^a   Khanna, Nehal ^a   Engineer, Reena ^a   Merchant, Nikhil H ^a   Deshpande, Deepak D ^a   Shrivastava, Shyamkishore ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cervical cancer; Clinical outcome; Dose volume parameters; Late toxicities; MR imageYbased brachytherapy

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER; BRACHYTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DERMATITIS; DIARRHEA; DISEASE FREE SURVIVAL; DOSIMETRY; DYSURIA; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTERMETHOD COMPARISON; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTUM; SIGMOID; TELANGIECTASIA; UTERINE CERVIX CANCER; VOMITING;

ADENOCARCINOMA; ADULT; AGED; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; EUROPE; FEMALE; HUMANS; INDIA; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY DOSAGE; RECTUM; SURVIVAL ANALYSIS; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 83055178963     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31821caa55     Document Type: Article

References (25)

1. Eifel PJ, Thomas WW, Smith TL, et al. The relationship between brachytherapy dose and outcome in patients with bulky endo-cervical tumors treated with radiation alone. Int J Radiat Oncol Biol Phys. 1994;28:113Y118. (Pubitemid 24012862)
2. ICRU Report No. 38. Dose and volume specification for reporting Intracavitary therapy in Gynecology. Bethesda, MD: International Commission on Radiation Units and Measurements; 1985.
3. Pelloski CE, Palmer M, Chronowski GM, et al. Comparison between CT-based volumetric calculations and ICRU reference point estimates of radiation doses delivered to bladder and rectum during Intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005;62:131Y137. (Pubitemid 40591934)
4. Erickson B. MRI and ultrasound guide gynecologic brachytherapy. Diagn Imaging. 2000;22:78Y83.
5. Mutic S, Grigsby P, Low D, et al. PET-Guided three-dimensional treatment planning of Intracavitary GYN Implants. Int J Radiat Oncol Biol Phys. 2002;52:1104Y1111.
6. Viswanathan A, Dimopoulos J, Kirisits C, et al. Computed tomography versus magnetic resonance imaging based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007;68:491Y498. (Pubitemid 46694166)
7. Lindegaard JC, Tanderup K, Nielsen SK, et al. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71:756Y764.
8. Wachter-Gerstner N, Wachter S, Reinstadler E, et al. The impact of sectional imaging on dose escalation in endocavitary brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother Oncol. 2003;68:51Y59. (Pubitemid 37289336)
9. Haie-Meder C, Potter R, Van Limbergen E, et al. Recommendations from Gynecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother. Oncol. 2005;74:235Y245. (Pubitemid 40349132)
10. Potter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): concepts and terms in 3D imageYbased treatment planning in cervix cancers brachytherapy 3D dose volume parameters and aspects of 3D imageYbased anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67Y77. (Pubitemid 43131038)
11. Potter R, Dimopoulos J, George P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol. 2007;83:148Y155. (Pubitemid 46783926)
12. Potter R, Dimopoulos J, Bachtiary B, et al. 3D conformal HDR-brachy- and external beam therapy plus simultaneous Cisplatin for high-risk cervical cancer: clinical experience with 3-year follow-up. Radiother Oncol. 2006;79:80Y86.
13. De Brabandere M, Mousa AG, Nulens A, et al. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol. 2008;88:217Y226.
14. Chargari C, Magne N, Dumas I, et al. Physics contributions and clinical outcome with 3D-MRIYbased pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys. 2009;74:133Y139.
15. Tongaonkar HB. In: Evidence Based Management Guidelines, Gynecological Cancers Vol. III Tata Memorial Centre. 2004; 7Y9.
16. Kirisits C, Potter R, Stefan L, et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancers. Int J Radiat Oncol Biol Phys. 2005;62:901Y911. (Pubitemid 40779785)
17. Kirisits C, Lang S, Dimopoulos J, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys. 2006;65:624Y630.
18. Cheng JC, Peng LC, Chen YH, et al. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy. Int J Radiat Oncol Biol Phys. 2003;57: 1010Y1018. (Pubitemid 37324119)
19. Koom W S, Sohn DK, Kim JY, et al. Computed tomographyYbased high doseYrate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys. 2007;68:1446Y1454. (Pubitemid 47176797)
20. Al-Booz H, Boiangiu I, Appleby H, et al. Sigmoid colon an unexpected organ at risk in brachytherapy for cervix cancer. Egypt Natl Cancer Inst. 2006;18:156Y160.
21. Leborgne F, Fowler JF, Leborgne JH, et al. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix. Radiat Oncol Investig. 1997;5:289Y299. (Pubitemid 28018591)
22. van Den Bergh F, Meertens H, Moonen L, et al. The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol. 1998;47:85Y90. (Pubitemid 28218876)
23. Holloway C, Racine M, Cormack R, et al. Sigmoid dose using 3D imaging in cervical-cancer. Radiother Oncol. 2009;93:307Y310.
24. Jamema SV, Saju S, Mahantshetty U, et al. Dosimetric evaluation of rectum and bladder using image based CT planning and orthogonal radiographs with ICRU 38 recommendations in intracavitary brachytherapy. J Med Phys. 2007;33:3Y8.
25. Jamema SV, Kirisits C, Mahantshetty U, et al. Loading pattern calculated by inverse optimization Vs traditional dosimetry systems of intracavitary brachytherapy of cervical cancers Y a dosimetric study. Brachytherapy. 2009;8:127Y128.